The needlestick safety injection devices market is anticipated to grow

An exponential increase in the annual cost burden due to needlestick injuries, has fueled a corresponding rise in demand for safe and highly advanced safety devices to be developed by the stakeholders engaged in the healthcare industry to generate a stringent regulation for the prevention of needle-stick injuries.

Roots Analysis has announced the addition of “Needlestick Safety Injection Devices Market, 2022-2035” report to its list of offerings.

 

Given the inherent benefits of needlestick safety injection devices, number of developers have launched their proprietary devices for minimizing the risk of needlestick injuries. Moreover, stringent regulatory requirements have further prompted the stakeholders to improve product design and integrate better safety measures in their products, including needle shielding.

 

 

Key Market Insights

 

Currently, around 120 needlestick safety injection devices are available in the market

More than 35% of these injection devices are needles having the ability to retract or shield, followed by syringes (30%). It is worth noting that more than 90% of the needlestick safety injection devices are non-reusable (intended for single use) thereby reducing the chances of blood borne pathogen infections.

 

Over 50 companies claim to develop needlestick safety injection devices, worldwide

Presently, the market is dominated by very small companies (33%) and small companies (25%). It is worth noting that majority (40%) of the firms engaged in this domain are based in Europe, followed by North America (39%).

 

Partnership activity within this field has grown significantly between 2020 and 2022

Maximum number of partnerships (31%) were established in 2020 indicating a recent rise in the interest of developers engaged in the development of needlestick safety injection devices. It is worth highlighting that majority of the deals were acquisitions.

 

Over USD 260 million has been invested by both private and public investors, since 2016

Companies involved in the development of needlestick safety injection devices have raised around USD 70 million through venture funding, which represents 25% of the total capital raised in the given time period. Overall, around 20 investors have actively financed various projects / initiatives in this domain.

 

Close to 20 global events were organized in the past couple of years in this industry

Majority of the events related to needlestick safety injection device were organized in North America (22%). It is worth highlighting that the main agenda of these events was to discuss role of needlestick safety injection devices to prevent the needlestick injuries.

 

More than 140 patents have been filed / granted related to needlestick safety injection devices, since 2018

Of these, over 60 patents were filed / granted in 2022 (till April). Industry players that have filed maximum number of patents related to needlestick safety injection devices include (in decreasing order of number of patents filed) BD, West Pharmaceutical Services, B. Braun, Retractable Technologies and Safety Syringes.

 

North America and Europe are anticipated to capture more than 75% of the market by 2035

Growth in this domain is anticipated to be primarily driven by the rising cases of needlestick injuries amongst the healthcare workers. The Asia-Pacific needlestick safety injection devices market currently accounts for more than 20% of the global market.

 

 

To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/needlestick-safety-market/request-sample.html

 

                                                                                     

Key Questions Answered

  • Who are the leading needlestick safety injection devices developers?
  • Which are the popular types of safety injection devices available in this market?
  • What are the key challenges faced by stakeholders engaged in the development of needlestick safety injection devices?
  • What types of partnership models are commonly being adopted by stakeholders in this industry?
  • How has the intellectual property landscape of needlestick safety injection devices developers evolved over the years?
  • Which factors are likely to influence the evolution of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

 

The research also includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), details on product portfolio, recent developments, and an informed future outlook.

  • Braun
  • BD
  • Gerresheimer
  • HTL-STREFA
  • Nipro Europe Group Companies
  • SOL-MILLENNIUM Medical Group

 

For additional details, please visit https://www.rootsanalysis.com/reports/needlestick-safety-market.html  or email sales@rootsanalysis.com

 

 

You may also be interested in the following titles:

  1. Targeted protein degradation market, 2022-2035
  2. Cell Therapy Manufacturing Market, 2021-2030
  3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

 

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

Leave a Reply